A Phase I Platform Study of Rucaparib in Metastatic Castrate-resistant Prostate Cancer: Evaluation of Dose and Safety/tolerability of a Combination of Rucaparib with Androgen Receptor Inhibitors and/or Immunotherapy

Project: Research project

Project Details

Description

A Phase I Platform Study of Rucaparib in Metastatic Castrate-resistant Prostate Cancer: Evaluation of Dose and Safety/tolerability of a Combination of Rucaparib with Androgen Receptor Inhibitors and/or Immunotherapy
StatusActive
Effective start/end date9/1/199/30/24

Funding

  • CLOVIS ONCOLOGY, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.